Published in Brain Res Mol Brain Res on July 01, 1996
5-Hydroxytryptamine2A serotonin receptors in the primate cerebral cortex: possible site of action of hallucinogenic and antipsychotic drugs in pyramidal cell apical dendrites. Proc Natl Acad Sci U S A (1998) 1.61
Impaired hippocampal-dependent learning and functional abnormalities in the hippocampus in mice lacking serotonin(1A) receptors. Proc Natl Acad Sci U S A (2000) 1.36
Transmitter receptors and functional anatomy of the cerebral cortex. J Anat (2004) 1.23
Striatal 5-HT1A receptor stimulation reduces D1 receptor-induced dyskinesia and improves movement in the hemiparkinsonian rat. Neuropharmacology (2008) 1.04
Presynaptic control of serotonin on striatal dopamine function. Psychopharmacology (Berl) (2010) 0.93
Cultured rat hippocampal neural progenitors generate spontaneously active neural networks. Proc Natl Acad Sci U S A (2002) 0.86
Serotonin receptor expression in human prefrontal cortex: balancing excitation and inhibition across postnatal development. PLoS One (2011) 0.86
EEG effects of buspirone and pindolol: a method of examining 5-HT1A receptor function in humans. Psychopharmacology (Berl) (2003) 0.76
Psychedelics Recruit Multiple Cellular Types and Produce Complex Transcriptional Responses Within the Brain. EBioMedicine (2016) 0.75
Alteration of the platelet serotonin transporter in romantic love. Psychol Med (1999) 2.02
Binding profile of a novel cardioselective muscarine receptor antagonist, AF-DX 116, to membranes of peripheral tissues and brain in the rat. Life Sci (1986) 1.79
Gender-related differences in body dysmorphic disorder (dysmorphophobia). J Nerv Ment Dis (1997) 1.53
Predictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy. Psychol Med (2010) 1.49
The distribution of 35S-chlorpromazine in mice studied by whole body autoradiography. Arch Int Pharmacodyn Ther (1965) 1.39
A quantitative study of the anticholinergic action of several tricyclic antidepressants on the rat isolated fundal strip. Br J Pharmacol (1972) 1.36
Influence of panic-agoraphobic spectrum symptoms on treatment response in patients with recurrent major depression. Am J Psychiatry (2000) 1.35
Studies on the in vitro interaction of electrical stimulation and Ca++ movement in sarcoplasmic reticulum. J Gen Physiol (1966) 1.28
Ectopic Hoxa2 induction after neural crest migration results in homeosis of jaw elements in Xenopus. Development (2000) 1.25
Prevalence of anxiety disorders comorbidity in bipolar depression, unipolar depression and dysthymia. J Affect Disord (1997) 1.21
Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry (1996) 1.18
Insight into illness in schizophrenia, schizoaffective disorder, and mood disorders with psychotic features. Am J Psychiatry (2001) 1.16
Prevalence of psychiatric disorders in thyroid diseased patients. Neuropsychobiology (1998) 1.14
Characterization of the muscarinic receptor subtypes in the rat urinary bladder. Eur J Pharmacol (1988) 1.10
Distribution and cellular localization of the serotonin type 2C receptor messenger RNA in human brain. Neuroscience (1999) 1.09
Fluvoxamine in the treatment of body dysmorphic disorder (dysmorphophobia). Int Clin Psychopharmacol (1996) 1.08
Characterization of a novel 5-HT4 receptor antagonist of the azabicycloalkyl benzimidazolone class: DAU 6285. Naunyn Schmiedebergs Arch Pharmacol (1992) 1.08
Characterization of muscarinic receptors in guinea pig ileum longitudinal smooth muscle. Mol Pharmacol (1988) 1.08
DNA methylation of embryogenic carrot cell cultures and its variations as caused by mutation, differentiation, hormones and hypomethylating drugs. Theor Appl Genet (1989) 1.07
Panic-agoraphobic spectrum: reliability and validity of assessment instruments. J Psychiatr Res (2001) 1.07
Inflammatory and neurodegenerative pathways in depression: a new avenue for antidepressant development? Curr Med Chem (2011) 1.06
Increase in striatal acetylcholine levels in vivo by piribedil a new dopamine receptor stimulant. Life Sci (1974) 1.06
Cytological evidence of transcription of highly repeated DNA sequences during the lampbrush stage in Triturus cristatus carnifex. Chromosoma (1980) 1.05
Binding and functional characterization of the cardioselective muscarinic antagonist methoctramine. J Pharmacol Exp Ther (1988) 1.03
Muscarinic receptor heterogeneity in guinea pig intestinal smooth muscle: binding studies with AF-DX 116. Eur J Pharmacol (1987) 1.01
The clinical impact of bipolar and unipolar affective comorbidity on obsessive-compulsive disorder. J Affect Disord (1997) 1.01
Risk factors for postpartum depression: the role of the Postpartum Depression Predictors Inventory-Revised (PDPI-R). Results from the Perinatal Depression-Research & Screening Unit (PNDReScU) study. Arch Womens Ment Health (2009) 0.99
The distribution of inhaled mercury(Hg203) vapors in the brain of rats and mice. J Neuropathol Exp Neurol (1969) 0.99
Azabicycloalkyl benzimidazolone derivatives as a novel class of potent agonists at the 5-HT4 receptor positively coupled to adenylate cyclase in brain. Naunyn Schmiedebergs Arch Pharmacol (1991) 0.99
Chronic mania. Family history, prior course, clinical picture and social consequences. Br J Psychiatry (1998) 0.98
Binding and functional profiles of the selective M1 muscarinic receptor antagonists trihexyphenidyl and dicyclomine. Br J Pharmacol (1986) 0.98
The psychotic spectrum: validity and reliability of the Structured Clinical Interview for the Psychotic Spectrum. Schizophr Res (2005) 0.97
Episodic course in obsessive-compulsive disorder. Eur Arch Psychiatry Clin Neurosci (1998) 0.96
Distribution of muscarinic receptor subtypes in rat brain as determined in binding studies with AF-DX 116 and pirenzepine. Life Sci (1987) 0.96
5-HT4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. Neuroreport (1994) 0.96
A psychoeducational program for weight loss in patients who have experienced weight gain during antipsychotic treatment with olanzapine. Pharmacopsychiatry (2008) 0.95
Affective comorbidity in panic disorder: is there a bipolar connection? J Affect Disord (1993) 0.95
Role of the hippocampus in the sex-dependent regulation of eating behavior: studies with kainic acid. Physiol Behav (1986) 0.94
Incorporation of tritiated uridine in nuclei of Triturus oocytes treated with alpha-amanitin. Exp Cell Res (1971) 0.92
The structure of lifetime panic-agoraphobic spectrum. J Psychiatr Res (2008) 0.91
Clozapine for treatment-refractory schizophrenia, schizoaffective disorder, and psychotic bipolar disorder: a 24-month naturalistic study. J Clin Psychiatry (2000) 0.91
Analgesia by nefopam: does it act through serotonin? Drugs Exp Clin Res (1991) 0.91
Frequency and clinical correlates of adult separation anxiety in a sample of 508 outpatients with mood and anxiety disorders. Acta Psychiatr Scand (2009) 0.91
Chromosomal localization of 18S + 28S and 5S Ribosomal RNA genes in evolutionarily diverse anuran amphibians. Chromosoma (1982) 0.90
The neurobiology of attraction. J Endocrinol Invest (2003) 0.90
Gender-mediated clinical features of depressive illness. The importance of temperamental differences. Br J Psychiatry (1990) 0.89
Prevalence, phenomenology and comorbidity of body dysmorphic disorder (dysmorphophobia) in a clinical population. Int J Psychiatry Clin Pract (1997) 0.89
Clinical subtypes of bipolar mixed states: validating a broader European definition in 143 cases. J Affect Disord (1997) 0.89
Clinical characteristics and treatment outcome of depression in patients with and without a history of emotional and physical abuse. J Psychiatr Res (2009) 0.89
Molecular cytogenetics of the ribosomal (18S + 28S and 5S) DNA loci in primitive and advanced urodele amphibians. Genome (1993) 0.88
Muscarinic receptor heterogeneity in smooth muscle: binding and functional studies with AF-DX 116. Trends Pharmacol Sci (1988) 0.88
Use of a standardized documentation system (BLIPS/BDP) in the conduct of a multicenter international trial comparing fluvoxamine, imipramine, and placebo. Psychopharmacol Bull (1986) 0.88
Effects of alpha-amanitin on Triturus lampbrush chromosomes. Exp Cell Res (1971) 0.87
Characterization of muscarinic receptor subtypes in human tissues. Life Sci (1988) 0.87
Serotonergic facilitation of acetylcholine release in vivo from rat dorsal hippocampus via serotonin 5-HT3 receptors. J Neurochem (1994) 0.87
Storage and release of acetylcholine in the isolated superior cervical ganglion of the rat. Brain Res (1978) 0.86
Peripheral markers of serotonin and dopamine function in obsessive-compulsive disorder. Psychiatry Res (1992) 0.86
Distribution of [3H]GR65630 binding in human brain postmortem. Neurochem Res (2001) 0.86
Response to ECT in bipolar I, bipolar II and unipolar depression. J Affect Disord (2009) 0.86
Awareness of illness and subjective experience of cognitive complaints in patients with bipolar I and bipolar II disorder. Am J Psychiatry (1999) 0.85
Decreased platelet 3H-paroxetine binding in obsessive-compulsive patients. Neuropsychobiology (1996) 0.85
Identification of serotonin 5-HT4 recognition sites in the porcine caudate nucleus by radioligand binding. Neuropharmacology (1994) 0.85
Electroconvulsive therapy in medication-nonresponsive patients with mixed mania and bipolar depression. J Clin Psychiatry (2001) 0.84
Distribution of 5-HT2c and 5-ht5a receptor mRNA in human brain. Ann N Y Acad Sci (1998) 0.84
Heterochromatic DNA in Triturus (Amphibia, Urodela). I. A satellite DNA component of the pericentric C-bands. Chromosoma (1986) 0.84
Headache, panic disorder and depression: comorbidity or a spectrum? Neuropsychobiology (1995) 0.84
Gypsy/Ty3-like elements in the genome of the terrestrial Salamander hydromantes (Amphibia, Urodela). J Mol Evol (1996) 0.83
Acceptability, validity and reliability of the Structured Clinical Interview for the Spectrum of Substance Use (SCI-SUBS): a pilot study. Int J Methods Psychiatr Res (2003) 0.83
Risperidone augmentation in refractory obsessive-compulsive disorder: an open-label study. Int Clin Psychopharmacol (2000) 0.83
Social class and mood disorders: clinical features. Soc Psychiatry Psychiatr Epidemiol (1993) 0.83
The lamphbrush chromosomes of Salamandra salamandra (L.) (Amphibia Urodela). Chromosoma (1969) 0.83
Decreased platelet 3H-paroxetine binding in untreated panic disorder patients. Life Sci (1999) 0.83
Determination of endogenous acetylcholine release in freely moving rats by transstriatal dialysis coupled to a radioenzymatic assay: effect of drugs. J Neurochem (1987) 0.83
Depression as seen by nonpsychiatrist physicians. Compr Psychiatry (1976) 0.83
Platelet [3H]paroxetine binding in patients with OCD-related disorders. Psychiatry Res (1999) 0.83
Acetylcholine, choline and choline acetyltransferase activity in the developing brain of normal and hypothyroid rats. J Neurochem (1972) 0.83
Impairment of work and leisure in depressed outpatients. A preliminary communication. J Affect Disord (1986) 0.82
The relationship between epilepsy and depression: an update. Curr Med Chem (2013) 0.82
The high prevalence of bipolar II and associated cyclothymic and hyperthymic temperaments in HIV-patients. J Affect Disord (1998) 0.82
Does psychomotor retardation define a clinically relevant phenotype of unipolar depression? J Affect Disord (2010) 0.82
Predictors of compliance with lithium and carbamazepine regimens in the long-term treatment of recurrent mood and related psychotic disorders. Pharmacopsychiatry (1989) 0.82
Decreased platelet [3H]paroxetine binding sites in suicide attempters. Psychiatry Res (2001) 0.82
Increased density of the platelet serotonin transporter in autism. Pharmacopsychiatry (2000) 0.82
A tandemly repeated DNA family originated from SINE-related elements in the European plethodontid salamanders (Amphibia, Urodela). J Mol Evol (1995) 0.82
Decreased Ca2+ uptake by sarcoplasmic reticulum after coronary artery occlusion for 60 and 90 minutes. Circ Res (1967) 0.81
Uptake of [14C]glutamine in the tissues of the mouse studied by whole-body autoradiography. J Neurochem (1966) 0.81
Therapeutic potential of CNS-active M2 antagonists: novel structures and pharmacology. Life Sci (1993) 0.81
Immunological alterations in adult obsessive-compulsive disorder. Biol Psychiatry (1999) 0.81
Abnormal peripheral benzodiazepine receptor density associated with generalized social phobia. Biol Psychiatry (1998) 0.81
Immune cell imbalance in major depressive and panic disorders. Neuropsychobiology (1992) 0.81
Prevalence of headache syndromes in panic disorder. Int Clin Psychopharmacol (1999) 0.81
Regulation of plasma aldosterone levels by metoclopramide: a reappraisal of its mechanism from dopaminergic antagonism to serotonergic agonism. Neuropharmacology (1997) 0.81
Benzimidazolones and renzapride facilitate acetylcholine release from guinea-pig myenteric plexus via 5-HT4 receptors. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.81